Lidocaine 2% without vessel constrictor (DrugBank: Lidocaine)
12 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
6 | パーキンソン病 | 0 |
13 | 多発性硬化症/視神経脊髄炎 | 0 |
34 | 神経線維腫症 | 0 |
46 | 悪性関節リウマチ | 0 |
51 | 全身性強皮症 | 1 |
70 | 広範脊柱管狭窄症 | 0 |
84 | サルコイドーシス | 0 |
86 | 肺動脈性肺高血圧症 | 0 |
168 | エーラス・ダンロス症候群 | 0 |
226 | 間質性膀胱炎(ハンナ型) | 0 |
231 | α1-アンチトリプシン欠乏症 | 0 |
256 | 筋型糖原病 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00740285 (ClinicalTrials.gov) | April 2004 | 19/8/2008 | Effectiveness and Safety of Lidocaine for Scleroderma | Effectiveness and Safety of Lidocaine for Scleroderma. Randomized Double-Blind Clinical Trial | Scleroderma | Drug: Lidocaine 2% without vessel constrictor;Other: Placebo - physiological solution 0,9% | Federal University of São Paulo | NULL | Completed | 18 Years | 60 Years | Both | 26 | Phase 2;Phase 3 | Brazil |